| Beyond platinums: gold complexes as anticancer agents C Nardon, G Boscutti, D Fregona Anticancer research 34 (1), 487-492, 2014 | 188 | 2014 |
| Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base–copper complexes J Zuo, C Bi, Y Fan, D Buac, C Nardon, KG Daniel, QP Dou Journal of Inorganic Biochemistry 118, 83-93, 2013 | 130 | 2013 |
| Noble metal-dithiocarbamates precious allies in the fight against cancer E Marta Nagy, L Ronconi, C Nardon, D Fregona Mini reviews in medicinal chemistry 12 (12), 1216-1229, 2012 | 86 | 2012 |
| Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics M Negom Kouodom, L Ronconi, M Celegato, C Nardon, L Marchio, ... Journal of medicinal chemistry 55 (5), 2212-2226, 2012 | 66 | 2012 |
| Targeting the ubiquitin–proteasome pathway with inorganic compounds to fight cancer: a challenge for the future L Dalla Via, C Nardon, D Fregona Future medicinal chemistry 4 (4), 525-543, 2012 | 66 | 2012 |
| Gold (III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: Preclinical studies against human breast neoplasia C Nardon, SM Schmitt, H Yang, J Zuo, D Fregona, QP Dou PloS one 9 (1), e84248, 2014 | 64 | 2014 |
| Gold complexes for therapeutic purposes: an updated patent review (2010-2015) C Nardon, N Pettenuzzo, D Fregona Current Medicinal Chemistry 23 (29), 3374-3403, 2016 | 54 | 2016 |
| Promising anticancer mono-and dinuclear ruthenium (III) dithiocarbamato complexes: systematic solution studies EM Nagy, C Nardon, L Giovagnini, L Marchiò, A Trevisan, D Fregona Dalton Transactions 40 (44), 11885-11895, 2011 | 38 | 2011 |
| Gold (III) complexes in the oncological preclinical arena: from aminoderivatives to peptidomimetics C Nardon, D Fregona Current topics in medicinal chemistry 16 (3), 360-380, 2016 | 37 | 2016 |
| Target selective micelles for bombesin receptors incorporating Au (III)-dithiocarbamato complexes P Ringhieri, R Iannitti, C Nardon, R Palumbo, D Fregona, G Morelli, ... International journal of pharmaceutics 473 (1-2), 194-202, 2014 | 36 | 2014 |
| Gold (III)–pyrrolidinedithiocarbamato derivatives as antineoplastic agents C Nardon, F Chiara, L Brustolin, A Gambalunga, F Ciscato, A Rasola, ... ChemistryOpen 4 (2), 183-191, 2015 | 31 | 2015 |
| Anticancer Gold (III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations G Boscutti, C Nardon, L Marchiò, M Crisma, B Biondi, D Dalzoppo, ... ChemMedChem 13 (11), 1131-1145, 2018 | 30 | 2018 |
| New comprehensive studies of a gold (III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream … MF Tomasello, C Nardon, V Lanza, G Di Natale, N Pettenuzzo, S Salmaso, ... European Journal of Medicinal Chemistry 138, 115-127, 2017 | 28 | 2017 |
| Ru (III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: Loading into nanocarriers and preliminary biological studies S Scintilla, L Brustolin, A Gambalunga, F Chiara, A Trevisan, C Nardon, ... Journal of Inorganic Biochemistry 165, 159-169, 2016 | 28 | 2016 |
| Preclinical activity of multiple-target gold (III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts M Celegato, D Fregona, M Mongiat, L Ronconi, C Borghese, V Canzonieri, ... Future Medicinal Chemistry 6 (11), 1249-1263, 2014 | 21 | 2014 |
| Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu (II) and Ru (III) aliphatic and aromatic dithiocarbamato complexes L Brustolin, C Nardon, N Pettenuzzo, NZ Fantoni, S Quarta, F Chiara, ... Dalton Transactions 47 (43), 15477-15486, 2018 | 20 | 2018 |
| Effect of the heteroaromatic antenna on the binding of chiral Eu (III) complexes to bovine serum albumin C De Rosa, A Melchior, M Sanadar, M Tolazzi, A Giorgetti, RP Ribeiro, ... Inorganic Chemistry 59 (17), 12564-12577, 2020 | 17 | 2020 |
| CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy N Pettenuzzo, L Brustolin, E Coltri, A Gambalunga, F Chiara, A Trevisan, ... ChemMedChem 14 (12), 1162-1172, 2019 | 17 | 2019 |
| Cell and Cell‐Free Mechanistic Studies on Two Gold (III) Complexes with Proven Antitumor Properties C Nardon, G Boscutti, C Gabbiani, L Massai, N Pettenuzzo, A Fassina, ... European Journal of Inorganic Chemistry 2017 (12), 1737-1744, 2017 | 17 | 2017 |
| CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics C Nardon, G Boscutti, L Dalla Via, P Ringhieri, V Di Noto, G Morelli, ... MedChemComm 6 (1), 155-163, 2015 | 16 | 2015 |
